Evofem Biosciences (EVFM) Competitors $0.01 0.00 (0.00%) As of 06/13/2025 03:40 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EVFM vs. RDHL, ADIL, MTNB, PLRZ, EVOK, GLTO, SXTP, THAR, EVAX, and TTNPShould you be buying Evofem Biosciences stock or one of its competitors? The main competitors of Evofem Biosciences include RedHill Biopharma (RDHL), Adial Pharmaceuticals (ADIL), Matinas Biopharma (MTNB), Polyrizon (PLRZ), Evoke Pharma (EVOK), Galecto (GLTO), 60 Degrees Pharmaceuticals (SXTP), Tharimmune (THAR), Evaxion Biotech A/S (EVAX), and Titan Pharmaceuticals (TTNP). These companies are all part of the "pharmaceutical products" industry. Evofem Biosciences vs. Its Competitors RedHill Biopharma Adial Pharmaceuticals Matinas Biopharma Polyrizon Evoke Pharma Galecto 60 Degrees Pharmaceuticals Tharimmune Evaxion Biotech A/S Titan Pharmaceuticals RedHill Biopharma (NASDAQ:RDHL) and Evofem Biosciences (NASDAQ:EVFM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations. Which has more volatility & risk, RDHL or EVFM? RedHill Biopharma has a beta of 4.23, indicating that its share price is 323% more volatile than the S&P 500. Comparatively, Evofem Biosciences has a beta of -1.01, indicating that its share price is 201% less volatile than the S&P 500. Does the media favor RDHL or EVFM? In the previous week, Evofem Biosciences had 1 more articles in the media than RedHill Biopharma. MarketBeat recorded 2 mentions for Evofem Biosciences and 1 mentions for RedHill Biopharma. RedHill Biopharma's average media sentiment score of 1.89 beat Evofem Biosciences' score of -0.50 indicating that RedHill Biopharma is being referred to more favorably in the media. Company Overall Sentiment RedHill Biopharma Very Positive Evofem Biosciences Negative Which has better valuation and earnings, RDHL or EVFM? Evofem Biosciences has higher revenue and earnings than RedHill Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRedHill Biopharma$8.04M0.50$23.92MN/AN/AEvofem Biosciences$11.39M0.10$52.98M-$0.05-0.20 Is RDHL or EVFM more profitable? RedHill Biopharma has a net margin of 0.00% compared to Evofem Biosciences' net margin of -46.42%. RedHill Biopharma's return on equity of 0.00% beat Evofem Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets RedHill BiopharmaN/A N/A N/A Evofem Biosciences -46.42%-91.97%-61.93% Do insiders & institutionals have more ownership in RDHL or EVFM? 7.2% of RedHill Biopharma shares are owned by institutional investors. Comparatively, 0.2% of Evofem Biosciences shares are owned by institutional investors. 6.8% of RedHill Biopharma shares are owned by insiders. Comparatively, 0.2% of Evofem Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor RDHL or EVFM? RedHill Biopharma received 165 more outperform votes than Evofem Biosciences when rated by MarketBeat users. However, 69.50% of users gave Evofem Biosciences an outperform vote while only 65.69% of users gave RedHill Biopharma an outperform vote. CompanyUnderperformOutperformRedHill BiopharmaOutperform Votes42765.69% Underperform Votes22334.31% Evofem BiosciencesOutperform Votes26269.50% Underperform Votes11530.50% SummaryRedHill Biopharma beats Evofem Biosciences on 9 of the 13 factors compared between the two stocks. Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EVFM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVFM vs. The Competition Export to ExcelMetricEvofem BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.19M$6.88B$5.57B$8.50BDividend YieldN/A2.48%5.27%4.17%P/E Ratio-0.028.4626.7519.66Price / Sales0.10261.91403.98152.07Price / CashN/A65.8538.2534.64Price / Book0.006.526.964.59Net Income$52.98M$143.26M$3.23B$248.23M7 Day PerformanceN/A-0.21%-1.22%-1.07%1 Month PerformanceN/A10.62%6.34%2.59%1 Year PerformanceN/A3.63%33.05%13.50% Evofem Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVFMEvofem Biosciences0.8047 of 5 stars$0.01flatN/A-23.1%$1.19M$11.39M-0.02120Short Interest ↑RDHLRedHill Biopharma1.0617 of 5 stars$2.05+3.0%N/A-99.3%$4.70M$8.04M0.00210ADILAdial Pharmaceuticals3.215 of 5 stars$0.57+0.5%$8.00+1,291.8%-73.3%$4.54MN/A-0.3920News CoverageShort Interest ↓Gap DownMTNBMatinas Biopharma1.0789 of 5 stars$0.88-5.4%N/AN/A$4.48M$1.10M-0.1830Short Interest ↓PLRZPolyrizonN/A$0.84+4.2%N/AN/A$4.46MN/A0.00N/ANews CoverageEVOKEvoke Pharma0.5695 of 5 stars$2.96+0.2%N/A-51.3%$4.41M$11.59M-0.274News CoverageGap UpGLTOGalecto2.4509 of 5 stars$3.29flat$10.00+204.0%-74.8%$4.35MN/A-0.1740Short Interest ↑SXTP60 Degrees Pharmaceuticals3.2198 of 5 stars$2.90-0.7%$7.00+141.4%+62.3%$4.27M$665.45K-0.293News CoverageAnalyst ForecastShort Interest ↓Gap UpTHARTharimmune3.0991 of 5 stars$1.60+6.0%$17.00+962.5%-61.5%$4.26MN/A-0.202News CoverageGap UpEVAXEvaxion Biotech A/S1.9764 of 5 stars$3.01-3.8%$10.00+232.2%-82.1%$4.22M$3.29M-2.0860Short Interest ↑TTNPTitan Pharmaceuticals1.1589 of 5 stars$4.58-1.6%N/A-36.1%$4.18M$180K-1.0010Short Interest ↓ Related Companies and Tools Related Companies RedHill Biopharma Alternatives Adial Pharmaceuticals Alternatives Matinas Biopharma Alternatives Polyrizon Alternatives Evoke Pharma Alternatives Galecto Alternatives 60 Degrees Pharmaceuticals Alternatives Tharimmune Alternatives Evaxion Biotech A/S Alternatives Titan Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVFM) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EVFM Stock Free EVFM Stock Alerts